lamivudine Hepatitis B

Hepatitis B is a deadly disease; this disease is one major threat to global health. It is estimated that 2 billion people around the world have been infected with HBV and around 350 million people have contracted chronic (long-term) hepatitis B infection. Moreover, approximately 500,000-700,000 people die from hepatitis B every year.

There are several reasons for the high burden of hepatitis B in the country. The two main reasons are lack of awareness of the disease coupled with inability to afford the expensive treatment.Not because the disease is deadly, but there is no cure, so far the powerful medicine for this disease is lamivudine hepatitis b. it works very well as treatment of chronic hepatitis B patients. This drug has been shown to decrease the amount of hepatitis B virus in the world in blood flow by a factor of 1,000. Some cases have also found that patients who received lamivudine hepatitis B had decreased liver inflammation, which in turn, reduces the amount of damage and the potential for liver cirrhosis. Some patients taking lamivudine hepatitis B also experienced healing of existing liver damage.